Related references
Note: Only part of the references are listed.ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression
Yizeng Fan et al.
CELL DEATH AND DIFFERENTIATION (2022)
Activation of TGF-β-SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK
Sirisha Natani et al.
CELLULAR SIGNALLING (2022)
Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves et al.
GENES (2021)
Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
Hon Yan Kelvin Yip et al.
CELLS (2021)
AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells
Sirisha Natani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
Nan Zhang et al.
LANCET ONCOLOGY (2021)
Tissue microarray profiling and integrative proteomics indicate the modulatory potential of Maytenus royleanus in inhibition of overexpressed TPD52 in prostate cancers
Maria Shabbir et al.
SCIENTIFIC REPORTS (2021)
Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance
Yuzo Abe et al.
CELL AND BIOSCIENCE (2021)
Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
Nurul Azwa Abd Wahab et al.
NUTRIENTS (2020)
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
Siyuan Cheng et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
Tae Jin Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46
Yen-Nien Liu et al.
CLINICAL CANCER RESEARCH (2019)
Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy
Sumanta K. Pal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration
Chandrashekhar Dasari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression
Divya Duscharla et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation
Patricia Mjones et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-B transactivation in LNCaP cells
Chandrashekhar Dasari et al.
TUMOR BIOLOGY (2017)
Positive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy - An analysis of outcomes from a UK tertiary referral centre
Ashwin Sachdeva et al.
BMC UROLOGY (2017)
Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
Ying Wang et al.
ONCOTARGET (2016)
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
Alessandra Bosutti et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma
Tomohiro Kumamoto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells
Tom Moritz et al.
TUMOR BIOLOGY (2016)
Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer
Nizam Uddin et al.
CANCER SCIENCE (2015)
Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure
Chang-Deng Hu et al.
FRONTIERS IN ONCOLOGY (2015)
Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death
Simeng Wen et al.
CANCER TREATMENT REVIEWS (2014)
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
Reng-Yun Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells
Pei-Ching Chang et al.
PLOS ONE (2014)
Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
Jennifer A. Byrne et al.
TUMOR BIOLOGY (2014)
Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage
Lei Li et al.
CARCINOGENESIS (2013)
The Role of Snail in EMT and Tumorigenesis
Yifan Wang et al.
CURRENT CANCER DRUG TARGETS (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer
Punit Saraon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The EMT regulator slug and lung carcinogenesis
Jin-Yuan Shih et al.
CARCINOGENESIS (2011)
The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro
C. Huang et al.
NEOPLASMA (2011)
Disparities at Presentation, Diagnosis, Treatment, and Survival in African American Men, Affected by Prostate Cancer
Ganna Chornokur et al.
PROSTATE (2011)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma
Seong-Su Han et al.
MOLECULAR CANCER (2010)
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52
Mona Shehata et al.
CLINICAL CANCER RESEARCH (2008)
Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells
Ramesh Ummanni et al.
FEBS JOURNAL (2008)
Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment
Joyce C. Tse et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52
Jennifer D. Lewis et al.
MOLECULAR CANCER RESEARCH (2007)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
N Vashchenko et al.
EUROPEAN UROLOGY (2005)
IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells
KT Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications
B Dalby et al.
METHODS (2004)
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer
A Scholz et al.
GASTROENTEROLOGY (2003)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Neuropeptide receptor status in human tumor cell lines
T Petit et al.
ANTI-CANCER DRUGS (2001)
Share Paper
